Alkylating agents - PDFSEARCH.IO - Document Search Engine

Alkylating agents
Results: 211

#	Item
71	Carboplatin Injection Progression-Free Survival (PFS) NCIC Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2013-11-01 11:16:00 Carboplatin Cisplatin Ototoxicity Creatinine National Cancer Institute Thrombocytopenia Gemcitabine Triplatin tetranitrate Chemistry Alkylating antineoplastic agents Ammine complexes
72	------------CONTRAINDICATIONS[removed]Patients with a known hypersensitivity to gemcitabine (4) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-03-07 09:45:13 Eli Lilly and Company Organofluorides Gemcitabine Carboplatin Lung cancer Pulmonary toxicity Cisplatin Pancreatic cancer Lipoplatin Chemistry Alkylating antineoplastic agents Ammine complexes
73	Mesna Injection 100 mg per mL IV-IV-IV Regimen After intravenous administration of an 800-mg dose, the half-lives of mesna and dimesna in the blood are 0.36 hours and 1.17 hours, respectively. Approximately 32% and 33% Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-10-01 09:05:22 Alkylating antineoplastic agents Nitrogen mustards Mesna Thiols Cyclophosphamide Hemorrhagic cystitis Ifosfamide Lorazepam Methadone Chemistry Organic chemistry Organochlorides
74	BMT CLINICAL TRIALS NETWORK RIC vs. MAC – Protocol # 0901 Version 5.0 dated March 3, 2014 PROTOCOL SYNOPSIS – BMT CTN 0901 PROTOCOL Add to Reading List Source URL: web.emmes.com Language: English - Date: 2014-03-03 15:24:04 Alkylating antineoplastic agents Fludarabine Organofluorides Organophosphates Purines Myeloid leukemia Hematopoietic stem cell transplantation Busulfan Cyclophosphamide Medicine Chemistry Oncology
75	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Ifosfamide for Injection safely and effectively. See full prescribing information for Ifosfamide for Injection. Ifos Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-09-02 17:55:37 Alkylating antineoplastic agents Organochlorides Nitrogen mustards Hemorrhagic cystitis Ifosfamide Chemotherapy Cystitis Mesna Ketorolac Medicine Chemistry Organic chemistry
76	These highlights do not include all the information needed to use Oxaliplatin Injection, USP safely and effectively. See full prescribing information for Oxaliplatin Injection, USP. Oxaliplatin Injection, USP, for intrav Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-11-10 10:45:31 Chemotherapy regimens Oxaliplatin Organofluorides FOLFOX Prodrugs Fluorouracil Esophageal cancer Adjuvant therapy Irinotecan Chemistry Alkylating antineoplastic agents Ammine complexes
77	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use docetaxel injection concentrate safely and effectively. See full prescribing information for docetaxel injection con Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-09-19 13:55:51 Carbamates Cancer treatments Alkaloids Benzoates Docetaxel Chemotherapy Prostate cancer Lung cancer Cyclophosphamide Chemistry Medicine Alkylating antineoplastic agents
78	Treanda (bendamustine hydrochloride) Full Safety and Drug Utilization Review Provided in Background Materials Pediatric Advisory Committee Meeting, September 23, 2014 Add to Reading List Source URL: www.fda.gov Language: English Bendamustine Benzimidazoles Organochlorides Medicine Oncology Orphan drugs B-cell chronic lymphocytic leukemia Rituximab Alkylating antineoplastic agents Nitrogen mustards Chemistry
79	Sagent Pharmaceuticals, Inc. Oxaliplatin Injection, USP / Oxaliplatin for Injection, USP Safety Data Sheet (SDS) Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-11-10 10:45:28 Material safety data sheet SDS-PAGE Chemistry Alkylating antineoplastic agents Oxaliplatin
80	Protocol #[removed]RAC Presentation E10A (Endostatin Adenovirus) for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck George Yoo, M.D., FACS PI, Head and Neck Surgery, Karmanos Cancer Cen Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 12:04:40 Bristol-Myers Squibb Angiogenesis inhibitors Alkylating antineoplastic agents Endostatin Proteins Gastrointestinal cancer Cetuximab Head and neck cancer Lung cancer Medicine Chemistry Oncology

UPDATE